Siblia
Phage Display Vaccines: New Possibilities for Antigen Presentation and Vaccine Research
A 2026 study of a lambda phage platform targeting EGFRvIII highlights the potential of multivalent antigen display, while underscoring the challenges of translating experimental vaccine designs into effective immunization strategies. What the 2026 EGFRvIII Study Demonstrated In March 2026, NIH-affiliated scientists reported a lambda (λ) bacteriophage engineered to display an...
575 Weergaven
© 2026 Siblia Online: 14 Vandaag: 208 Yesterday: 380 This Week: 759 This Month: 759 This Year: 759 Totaal: 759 Visitor Analytics